La NMPA de China aprueba la comercialización de Ganagliflozin Proline Tablets

📩 info@dengyuemed.com
🔗https://dengyuepharma.com

#NMPA #ChinaDrugApproval #GanagliflozinProline #SGLT2Inhibitor #Type2Diabetes #InnovativeDrug #PharmaceuticalNews

China’s NMPA Approves Sentagliptin Phosphate Tablets for Market Launch

📩 info@dengyuemed.com
🔗https://dengyuemed.com

#ChinaDrugApproval #NMPA #SentagliptinPhosphate #Type2Diabetes #InnovativeMedicine #Shengjievi #Biopharma #Suzhou

China NMPA Approves Pradefovir Mesylate Tablets for Marketing

📩 info@dengyuemed.com
🔗https://dengyuemed.com

#NMPA #ChinaDrugApproval #PradefovirMesylate #Xinshumu #HepatitisB #InnovativeDrug #XiAnGelanXintong #PharmaceuticalNews